Original Antigenic Sin on Antibody Response in SARS-CoV-2 Infection

被引:0
|
作者
Wang, Miao [1 ]
Guo, Huimin [1 ]
Ju, Bin [1 ,2 ]
Zhang, Zheng [1 ,2 ,3 ]
机构
[1] Southern Univ Sci & Technol, Shenzhen Peoples Hosp 3, Affiliated Hosp 2, Inst Hepatol,Sch Med ,Natl Clin Res Ctr Infect Dis, Shenzhen 518112, Guangdong Provi, Peoples R China
[2] Guangdong Key Lab Antiinfect Drug Qual Evaluat, Shenzhen 518112, Guangdong Provi, Peoples R China
[3] Chinese Acad Med Sci, Shenzhen Res Ctr Communicable Dis Diag & Treatment, Shenzhen 518112, Guangdong Provi, Peoples R China
来源
INFECTIOUS DISEASES & IMMUNITY | 2024年 / 4卷 / 03期
基金
中国国家自然科学基金;
关键词
SARS-CoV-2; Original antigenic sin; Antibody response; Omicron subvariants; Vaccine design; CELLS;
D O I
10.1097/ID9.0000000000000125
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Infection and vaccination can provide protective immunity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). However, the emergence of SARS-CoV-2 variants has persisted, leading to breakthrough infections. Owing to the original antigenic sin (OAS), variant breakthrough infection or vaccination potentially induces a stronger antibody response against the ancestral strain than to subsequent variants, as in the case of influenza. Thus, overcoming OAS is important for the development of future vaccine designs. This review summarizes the recent findings on OAS in the antibody response to SARS-CoV-2 and its variants, with an emphasis on future vaccine designs.
引用
收藏
页码:132 / 137
页数:6
相关论文
共 50 条
  • [1] "Original Antigenic Sin" in SARS-CoV-2 Vaccination Followed by Infection
    Castillo-Aleman, Yandy M.
    Villegas-Valverde, Carlos A.
    Ventura-Carmenate, Yendry
    Suarez-Formigo, Gisela M.
    Bencomo-Hernandez, Antonio A.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (12)
  • [2] SARS-CoV-2 vaccination in the context of original antigenic sin
    Petras, Marek
    Kralova Lesna, Ivana
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2022, 18 (01)
  • [3] Impact of antigenic evolution and original antigenic sin on SARS-CoV-2 immunity
    Aguilar-Bretones, Muriel
    Fouchier, Ron A. M.
    Koopmans, Marion P. G.
    van Nierop, Gijsbert P.
    JOURNAL OF CLINICAL INVESTIGATION, 2023, 133 (01):
  • [4] SARS-CoV-2 vaccination washes away original antigenic sin
    Pillai, Shiv
    TRENDS IN IMMUNOLOGY, 2022, 43 (04) : 271 - 273
  • [5] Original antigenic sin and childhood immune responses against SARS-CoV-2
    Cobey, Sarah
    Hensley, Scott E.
    SCIENCE, 2022, 377 (6611) : 1148 - 1149
  • [6] What about the original antigenic sin of the humans versus SARS-CoV-2?
    Roncati, Luca
    Palmieri, Beniamino
    MEDICAL HYPOTHESES, 2020, 142
  • [7] The Antibody Response to SARS-CoV-2 Infection
    Hueston, Linda
    Kok, Jen
    Guibone, Ayla
    McDonald, Damien
    Hone, George
    Goodwin, James
    Carter, Ian
    Basile, Kerri
    Sandaradura, Indy
    Maddocks, Susan
    Sintchenko, Vitali
    Gilroy, Nicole
    Chen, Sharon
    Dwyer, Dominic E.
    O'Sullivan, Matthew V. N.
    OPEN FORUM INFECTIOUS DISEASES, 2020, 7 (09):
  • [8] SARS-CoV-2 infections elicit higher levels of original antigenic sin antibodies compared with SARS-CoV-2 mRNA vaccinations
    Anderson, Elizabeth M.
    Li, Shuk Hang
    Awofolaju, Moses
    Eilola, Theresa
    Goodwin, Eileen
    Bolton, Marcus J.
    Gouma, Sigrid
    Manzoni, Tomaz B.
    Hicks, Philip
    Goel, Rishi R.
    Painter, Mark M.
    Apostolidis, Sokratis A.
    Mathew, Divij
    Dunbar, Debora
    Fiore, Danielle
    Brock, Amanda
    Weaver, JoEllen
    Millar, John S.
    DerOhannessian, Stephanie
    Greenplate, Allison R.
    Frank, Ian
    Rader, Daniel J.
    Wherry, E. John
    Bates, Paul
    Hensley, Scott E.
    CELL REPORTS, 2022, 41 (03):
  • [9] Possible effect of the "original antigenic sin" in vaccination against new variants of SARS-CoV-2
    Reina, J.
    REVISTA CLINICA ESPANOLA, 2022, 222 (02): : 91 - 92
  • [10] The early antibody response to SARS-Cov-2 infection
    Dittadi, Ruggero
    Afshar, Haleh
    Carraro, Paolo
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2020, 58 (10) : E201 - E203